Zobrazeno 1 - 10
of 1 493
pro vyhledávání: '"daas"'
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 11, Pp 2115-2132 (2024)
Mohsen Salama,* Nehad Darwesh,* Maha Mohammad Elsabaawy,* Eman Abdelsameea,* Asmaa Gomaa,* Aliaa Sabry* Department of Hepatology and Gastroenterology, National Liver Institute, Menofia University, Shebeen El-Kom, Menofia, Egyp
Externí odkaz:
https://doaj.org/article/d122c8dab3474b9c818f4181a639cbca
Autor:
Xiaobo Zhu, Linna Jia, Ming Yue, Amei Zhang, Xueshan Xia, Rongbin Yu, Hongbo Chen, Peng Huang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract The long-term benefits of direct-acting antiviral (DAA) therapy after achieving sustained virological response (SVR) remain uncertain in the Chinese population. This study evaluates the incidence of hepatocellular carcinoma (HCC), hepatic de
Externí odkaz:
https://doaj.org/article/daa923918de047f68a20d42d20ca897c
Publikováno v:
Journal of Biological Dynamics, Vol 18, Iss 1 (2024)
In a recent study, a mathematically identical ODE model is derived from a multiscale PDE model of hepatitis C virus infection, which helps to overcome the limitations of the PDE model in the analysis. Here, an extended proposed model is formulated fo
Externí odkaz:
https://doaj.org/article/7c8e04621bcc4914b976db093c6d06eb
Autor:
Walaa Ramadan Allam, Mohamed Tharwat Hegazy, Mohamed A. Hussein, Naguib Zoheir, Luca Quartuccio, Sherif F. El-Khamisy, Gaafar Ragab
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The treatment of HCV and its sequelae are used to be predominantly based on Interferon (IFN). However, this was associated with significant adverse events as a result of its immunostimulant capabilities. Since their introduction, the directl
Externí odkaz:
https://doaj.org/article/21be55ec40a74412bb0b72bdc09439ca
Autor:
V. E. Ekushov, A. V. Totmenin, L. G. Gotfrid, M. R. Halikov, V.-V. V. Minikhanova, S. E. Skudarnov, T. S. Ostapova, N. M. Gashnikova
Publikováno v:
Юг России: экология, развитие, Vol 19, Iss 1, Pp 47-59 (2024)
To research the molecular genetic characteristics of the HCV population circulating among HIV‐infected residents of the Krasnoyarsk Territory, including analysis of resistance‐associated mutations to NS5A inhibitors. Total RNA was isolated from 9
Externí odkaz:
https://doaj.org/article/8a430f7f0d5647e2b6c24d31d9a9538b
Autor:
Mohamed Elbadry, Mahmoud Badawi, Naglaa Youssef, Martin Duracinsky, Shereen A. Saleh, Anna Funk, Hagar Elessawy, Eva Rumpler, Khadiga Sayed, Anca Vasiliu, Yoann Madec, Arnaud Fontanet, Mohamed El-Kassas
Publikováno v:
Egyptian Liver Journal, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Background Chronic hepatitis C virus (HCV) infection negatively impacts health-related quality of life (HRQL). We aimed to assess patient-reported outcomes (PROs) to evaluate the impact of treating chronic HCV with directly acting antivirals
Externí odkaz:
https://doaj.org/article/694fde0c1c3c4f92a91bd2e8f8ad76af
Autor:
Ivana Milošević, Ana Filipović, Branko Beronja, Nikola Mitrović, Maja Ružić, Jelena Simić, Nataša Knežević, Maria Pete, Nevena Todorović, Nataša Nikolić
Publikováno v:
Microorganisms, Vol 12, Iss 10, p 2050 (2024)
This study, conducted at two university-based infectious disease clinics, included 216 patients with chronic hepatitis C. The primary objective was to assess the positive and negative predictive values, sensitivity, and specificity of achieving a sus
Externí odkaz:
https://doaj.org/article/9c9165586b5a4190bd10d815464505f8
Autor:
Andri Sanityoso Sulaiman, Irsan Hasan, Cosmas Rinaldi Adithya Lesmana, Juferdy Kurniawan, Gita Aprilicia, Yayah Nugroho, Nunuk Tri Wahyuni, Budiman Sujatmika Sulaiman
Publikováno v:
Jurnal Penyakit Dalam Indonesia, Vol 10, Iss 4, Pp 183-188 (2023)
Introduction. Direct-acting antivirals (DAAs) has been developed for treatment hepatitis C virus (HCV). Therapy of HCV using DAA has shown high sustained virologic response (SVR) and shortening duration of therapy. Sofosbuvir-ledipasvir (SOF/LDV) i
Externí odkaz:
https://doaj.org/article/4f85095e1e2040a09afb750be04fd5b6
Publikováno v:
Liver Research, Vol 7, Iss 4, Pp 361-364 (2023)
Although direct-acting antivirals (DAAs) have notably increased the sustained virological response (SVR) rates in hepatitis C virus (HCV)-infected adolescent patients, the efficacy and safety for young children under 3 years old remain unclear. Curre
Externí odkaz:
https://doaj.org/article/6c43d2c02ba243b2967b3743565edd83
Autor:
Mahmoud M. Elnokeety, Rasha Ahmed Darwish, Mohamed Tharwat Hegazy, Sameh Abouzeid, Ahmed Fayed
Publikováno v:
Renal Replacement Therapy, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Background Hepatitis C virus (HCV) infection is linked to a higher mortality rate in hemodialysis (HD) patients. We aimed to see if HCV eradication using interferon-free direct acting antivirals (DAAs) can affect bone-mineral and anemia bioc
Externí odkaz:
https://doaj.org/article/8cb82340c1aa48f5b146ec682445a6cf